MODEL VERDICT
The Clorox Company (CLX)
Relative Valuation•Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
Each row records the model's monthly assessment. High Conviction = the model detected notable undervaluation vs peers. Neutral = no notable divergence was found. The return column shows the actual price change over 90 days for reference. This is a quantitative observation log — not investment advice.
| Date | Assessment | Score | Price | Status | 90d Fwd Return |
|---|---|---|---|---|---|
| May 1, 2026 | MODERATE | 0.68 | $87.11 | CURRENT | — |
| Apr 24, 2026 | MODERATE | 0.68 | $98.68 | CURRENT | — |
| Apr 17, 2026 | MODERATE | 0.61 | $104.58 | CURRENT | — |
| Apr 16, 2026 | MODERATE | 0.61 | $102.92 | CURRENT | — |
| Apr 10, 2026 | MODERATE | 0.68 | $105.28 | CURRENT | — |
Historical model observations for research purposes only. Past quantitative patterns do not predict future results. Not a recommendation to buy, sell, or hold any security.
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| Forward P/E 8 analyst estimates | $73.70 | -15.4% | 20% | A- | Analyst Est. |
| EV/EBITDA 8 industry peers | $116.67 | +33.9% | 20% | A- | Peer Data |
| Industry Median P/E 7 industry peers | $139.62 | +60.3% | 15% | A | Peer Data |
| Price / Free Cash Flow 8 industry peers | $120.72 | +38.6% | 15% | B+ | Peer Data |
| EV/EBIT 8 industry peers | $156.85 | +80.1% | 8% | B+ | Peer Data |
| EV/FCF 8 industry peers | $120.56 | +38.4% | 7% | B | Model Driven |
| EV To Revenue 8 industry peers | $79.58 | -8.6% | 4% | B | Data |
| Price / Sales 8 industry peers | $69.32 | -20.4% | 3% | B | Model Driven |
| Earnings Yield 7 industry peers | $139.84 | +60.5% | 2% | B | Data |
| FCF Yield 8 industry peers | $120.36 | +38.2% | 1% | B | Data |
| Weighted Output Blended model output | $141.12 | +62.0% | 100% | 78 | SIGNIFICANTLY UNDERVALUED |
| EPS Growth ↓ | P/E Multiple → | 9× | 11× | 13× (Current) | 15× | 17× |
|---|---|---|---|---|---|
| Bear Case (2%) | $60 | $73 | $86 | $100 | $113 |
| Conservative (5%) | $62 | $75 | $89 | $103 | $116 |
| Base Case (-2.4%) | $57 | $70 | $83 | $95 | $108 |
| Bull Case (-3%) | $57 | $69 | $82 | $95 | $107 |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
| Multiple | Avg | Median | Min | Max | Std |
|---|---|---|---|---|---|
| P/E Ratio | 46.73 | 31.25 | 15.46 | 118.83 | 36.56 |
| EV/EBIT | 30.63 | 25.22 | 12.93 | 59.43 | 16.29 |
| EV/EBITDA | 18.02 | 19.06 | 10.90 | 22.07 | 3.53 |
| P/FCF | 25.54 | 23.49 | 16.47 | 41.97 | 8.93 |
| P/FFO | 27.14 | 24.13 | 12.18 | 45.99 | 11.62 |
| P/AFFO | 46.81 | 37.68 | 15.49 | 112.78 | 33.24 |
| P/B Ratio | 34.03 | 35.65 | 23.85 | 45.64 | 8.17 |
| Div Yield | 0.03 | 0.03 | 0.02 | 0.05 | 0.01 |
| P/S Ratio | 2.79 | 2.86 | 1.76 | 3.84 | 0.66 |
Based on our peer multiples analysis with 26 valuation metrics, the model estimates CLX's fair value at $141.12 vs the current price of $87.11, implying +62.0% upside potential. Model verdict: Significantly Undervalued. Confidence: 78/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $141.12 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%). Monte Carlo simulation (10,000 iterations) gives a range of $117.52 (P10) to $165.84 (P90), with a median of $140.12.
CLX's current P/E of 13.4x compares to the industry median of 21.4x (7 peers in the group). This represents a -37.6% discount to the industry. The historical average P/E is 46.7x over 7 years. Signal: Deep Discount.
28 analysts cover CLX with a consensus rating of Hold. The consensus price target is $105.50 (range: $83.00 — $139.00), implying +21.1% upside from the current price. Grade breakdown: Strong Buy (0), Buy (4), Hold (19), Sell (5), Strong Sell (0).
The model confidence score is 78/100, based on: data completeness (27), peer quality (25), historical depth (20), earnings stability (4), and model agreement (2). Cyclicality penalty: -0 points. The model shows strong agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk refers to the possibility that CLX's current profitability is above its sustainable long-term trend. The model detects a margin Z-score of +0.5σ, meaning margins are 0.5 standard deviations above their historical average. If margins revert to the 7-year mean (8.7%), the model estimates fair value drops by 17130.0% to approximately $236. This isn't a prediction — it's a scenario analysis.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.